FDA rejects Myblu e-cigarette device marketing application

May 27, 2022 Leave a message

Relative security of Myblu devices

Meanwhile, a 2018 study presented at the First Science Summit, Reducing Tobacco Harm: New Products, Research and Policies, showed that levels of toxic substances in Myblu aerosols are 99 percent lower than those in cigarette smoke.

The study, entitled "Chemical Composition of MyBLu ™ POD-System E-Smoke Sol: A Quantitative Comparison with Conventional cigarette smoke", analysed 51 toxic substances of interest and found eight at quantifiable levels. These include formaldehyde, acetaldehyde and acrolein, which are still 99 percent lower than traditional cigarette smoke.

Aerosol chemistry was introduced by Grant O'Connell, Ph.D., Corporate Affairs Manager at Fontem Ventures, owner of the e-cigarette brand BLu. "Consistent with emerging clinical data, this study suggests that high-quality e-cigarette devices and e-liquids have the potential to significantly reduce exposure to carcinogens and toxic substances in smokers who use them as cigarette alternatives," he said.

Meeting standards is especially important

However, to the surprise of many, the FDA recently approved NJOY's low-nicotine e-cigarette. Brad Rodu, PhD, professor of medicine at the University of Louisville's Tobacco Harm Reduction Research and a noted tobacco harm researcher, stressed that many experts question how VLN cigarettes manage to meet the FDA's strict MRTP (Modified Risk Tobacco Products) standards, The standard requires products that "significantly reduce the harm and risk of tobacco-related disease to individual tobacco users and benefit the health of society as a whole, taking into account tobacco product users and people who do not currently use tobacco products."